MicrobiologyVirusesPeer-reviewed
NSC95397 is a Novel HIV-1 Latency Reversing Agent
Randilea Nichols Doyle, Vivian Yang, Yetunde I. Kayode…·Oliver I. Fregoso
This study identifies NSC95397 as a novel HIV-1 latency reversing agent that synergizes with existing LRAs and targets previously unrecognized pathways.
7 citations